Results 191 to 200 of about 55,909 (247)

Combating Campylobacter Resistance in Moroccan Poultry Using Essential Oil–Ciprofloxacin Combination

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
With an estimated prevalence of 15.52% in Moroccan poultry, Campylobacter species pose a significant food safety concern. We investigated whether essential oils (EOs) could restore the efficacy of ciprofloxacin against multidrug‐resistant (MDR) strains.
Zineb Soubai   +13 more
wiley   +1 more source

Molecular Characterisation and Antimicrobial Resistance Patterns of Listeria monocytogenes From Dairy Sources

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
This study presents a comprehensive surveillance of L. monocytogenes along the dairy supply chain, from raw milk collection to final products and environmental sources. The methodological framework encompasses conventional microbiological isolation and identification, followed by phenotypic antimicrobial susceptibility testing and calculation of the ...
Mohammad Reza Heidari   +3 more
wiley   +1 more source

Molecular Prevalence and Antimicrobial Resistance Patterns of Methicillin‐Resistant Staphylococcus aureus in Buffaloes from Bangladesh

open access: yesVeterinary Medicine and Science, Volume 12, Issue 6, November 2026.
Nasal swabs collected from 400 buffaloes were analysed to determine the prevalence, antimicrobial resistance and virulence characteristics of Staphylococcus aureus and MRSA. MRSA isolates exhibited extensive multidrug resistance and harboured multiple resistance and virulence genes, highlighting their pathogenic and zoonotic potential.
Piash Kumer Ghosh   +11 more
wiley   +1 more source

Ciprofloxacin

open access: yesDrug Intelligence & Clinical Pharmacy, 1987
Ciprofloxacin is a new fluorinated quinolone antibiotic with high activity against a wide spectrum of gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus, Enterobacteriaceae, and Pseudomonas aeruginosa. Clinical trials using the oral preparation of ciprofloxacin have demonstrated its effectiveness in a wide ...
D K, Terp, M J, Rybak
openaire   +3 more sources

Pharmacokinetics of ciprofloxacin

Infection, 1988
The fluorination of piperazinyl substituted quinolones has led to an interesting development of a series of new broad spectrum antibacterial agents that may be administered orally as well as parenterally and are well tolerated. Norfloxacin was an early compound, later followed by ciprofloxacin, enoxacin, ofloxacin and pefloxacin.
T, Bergan, A, Dalhoff, R, Rohwedder
openaire   +2 more sources

Intraperitoneal penetration of ciprofloxacin

European Journal of Clinical Microbiology, 1986
Ciprofloxacin, a quinolone derivative of carboxylic acid, has a spectrum of antimicrobial activity that includes the Enterobacteriaceae, Staphylococcus aureus and Pseudomonas aeruginosa (1). It may therefore prove useful, alone or in combination, in the prophylaxis or treatment of infections in patients undergoing abdominal surgery. Intraperitoneal and
M R, Lockley   +3 more
openaire   +2 more sources

Ciprofloxacin Crystal Nephropathy

American Journal of Kidney Diseases, 2007
Ciprofloxacin is a widely used fluoroquinolone for the treatment of patients with complicated and uncomplicated infections. With rare exceptions, only immune-mediated interstitial nephritis was described, with direct renal damage reported only in case of overdose.
STRATTA, Piero   +4 more
openaire   +3 more sources

CIPROFLOXACIN AND ANTACIDS

The Lancet, 1986
L C, Preheim   +4 more
openaire   +4 more sources

RESISTANCE TO CIPROFLOXACIN

The Lancet, 1985
S T, Chapman, D C, Speller, D S, Reeves
openaire   +2 more sources

CIPROFLOXACIN RESISTANCE

The Lancet, 1987
B, Salh, A K, Webb
openaire   +2 more sources

Home - About - Disclaimer - Privacy